Presently, Richard Paul Bryce holds the position of Chief Medical Officer for Rain Therapeutics, Inc. Dr. Bryce is also Member of American Society of Clinical Oncology, Member of The Royal College of Physicians, Member of American Association for Cancer Research, Member of American Society of Hematology, Member of European Society for Medical Oncology and Member of Royal College of General Practitioners.

Dr. Bryce previously occupied the position of President & Executive VP-Medical Affairs at Ergomed Plc, Director-Medical Affairs & Oncology at ICON plc and Senior Director-Medical Affairs & Oncology at ICON Clinical Research, Inc. (a subsidiary of ICON plc), Chief Medical & Scientific Officer at Puma Biotechnology, Inc. and Senior Medical Director at Onyx Pharmaceuticals, Inc.

He received a doctorate and an undergraduate degree from The University of Edinburgh.